LEGWRAP Sandal Fights Cancer

This spring, Stuart Weitzman’s sexy gladiator-inspired high heel LEGWRAP sandal will raise money to benefit Dr. Marsha A. Moses’ pioneering cancer research initiatives at the Folkman Institute in Boston, MA.

The LEGWRAP sandal, a red carpet staple, has been specially-created in four limited-edition colors – gold sparkle lame, sol suede, lipstick suede and navy antique denim – the proceeds from which will benefit Dr. Moses’ research on a wide range of cancers including ovarian and breast cancer. With a suggested retail price of $498each, this limited-edition charity program is available only at www.stuartweitzman.com and at Stuart Weitzman flagship boutiques in New York City (Madison Ave) and Beverly Hills (Rodeo Drive).

The Folkman Institute Vascular Biology Program at Boston Children’s Hospital, under the leadership of Director Marsha A. Moses, Ph.D., is a premier research center focused on cancer and angiogenesis, the growth of new blood vessels. It was founded by the late Dr. Judah Folkman, who first recognized that tumor growth beyond the microscopic size was dependent on angiogenesis. Today, the Institute develops diagnostics and therapies designed to detect and block angiogenesis and other processes that fuel cancer’s growth and spread. This is the third time Stuart Weitzman has raised money to support the groundbreaking work of Dr. Moses with his footwear designs. Previously, proceeds were donated from the Stuart Weitzman Young Hollywood Cares Collections.

Stuart Weitzman, a global leader in designer footwear, operates 46 retail stores across the United States, including New York, Beverly Hills, Chicago, Boston and Las Vegas. The company also has 73 international stores, 14 international shop-in-shops, and e-commerce sites in the United States, Canada, Europe and Hong Kong. Stuart Weitzman footwear and accessories are sold in more than 70 countries. Stuart Weitzman Holdings, LLC is a portfolio company of Sycamore Partners.

A luxury brand built upon the idea of creating a beautifully-constructed shoe, Stuart Weitzman’s main objective has always been to merge fashion and function. The first thing a women puts on in the morning and the last thing she takes off at night, founder and designer Stuart Weitzman’s shoes are engineered to feel as good as they look and to look as good as they feel.

Dr. Moses directs Boston Children’s Hospital’s Folkman Institute, one of the world’s leading cancer research centers. First to identify cancer-linked substances in patients’ urine, she is widely recognized for her pioneering research on urine tests to find the disease – and drugs to stop it. Two commercial tests based on her work, both for bladder cancer, are now available.

Dr. Moses’ research holds tremendous promise for a wide range of cancers, including ovarian and breast cancer, for which she has identified half-a-dozen urinary biomarkers. Her markers detect tumors the standard test misses, raising great hope of a simple, noninvasive test to find and monitor this notoriously difficult-to-detect cancer.